Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/mcp.M700006-MCP200 on September 11, 2007.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700006-MCP200v1
6/12/2150    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madoz-Gúrpide, J.
Right arrow Articles by Casal, J. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madoz-Gúrpide, J.
Right arrow Articles by Casal, J. I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 6:2150-2164, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.


Research

A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer*,S

Juan Madoz-Gúrpide{ddagger},§, Marta Cañamero, Lydia Sanchez||, José Solano**, Patricia Alfonso{ddagger} and J. Ignacio Casal{ddagger},{ddagger}{ddagger}

From the {ddagger} Protein Technology Unit, Comparative Pathology Unit, and || Histology and Immunohistochemistry Unit, Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), c/Melchor Fernández Almagro 3, 28029 Madrid, Spain and ** Servicio de Anatomia Patológica, Hospital Sta. María del Rosell, Cartagena, 30203 Murcia, Spain

To gain further insight into alterations in cellular pathways, tumor profiling, and marker discovery in colorectal cancer (CRC) we used a new antibody microarray specific for cell signaling. Soluble protein extracts were prepared from paired tumor/normal biopsies of 11 patients diagnosed with colorectal carcinoma at different stages; four liver carcinomas were used as a reference. Antibody microarray analysis identified 46 proteins that were differentially expressed between normal colorectal epithelium and adenocarcinoma. These proteins gave a specific signature for CRC, different from other tumors, as well as a panel of novel markers and potential targets for CRC. Twenty-four proteins were validated by using a specific colorectal cancer tissue microarray and immunoblotting analysis. Together with some previously well known deregulated proteins in CRC (β-catenin, c-MYC, or p63), we found new potential markers preferentially expressed in CRC tumors: cytokeratin 13, calcineurin, CHK1, clathrin light chain, MAPK3, phospho-PTK2/focal adhesion kinase (Ser-910), and MDM2. CHK1 antibodies were particularly effective in discriminating between tumoral and normal mucosa in CRC. Moreover a global picture of alterations in signaling pathways in CRC was observed, including a significant up-regulation of different components of the epidermal growth factor receptor and Wnt/β-catenin pathways and the down-regulation of p14ARF. The experimental approach described here should be applicable to other pathologies and neoplastic processes.


{ddagger}{ddagger} To whom correspondence should be addressed: Biotechnology Program, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain. Tel.: 34-91-224-69-20; Fax: 34-91-224-69-72; E-mail: icasal{at}cnio.es


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
I. Babel, R. Barderas, R. Diaz-Uriarte, J. L. Martinez-Torrecuadrada, M. Sanchez-Carbayo, and J. I. Casal
Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays
Mol. Cell. Proteomics, October 1, 2009; 8(10): 2382 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
Y. Ma, J. Peng, W. Liu, P. Zhang, L. Huang, B. Gao, T. Shen, Y. Zhou, H. Chen, Z. Chu, et al.
Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer
Mol. Cell. Proteomics, August 1, 2009; 8(8): 1878 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Ashwell and S. Zabludoff
DNA Damage Detection and Repair Pathways--Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy
Clin. Cancer Res., July 1, 2008; 14(13): 4032 - 4037.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement